Literature DB >> 23993204

Buccal mucosa graft for laryngotracheal reconstruction in severe laryngeal stenosis.

Lorraine A de Trey1, Gavin A Morrison.   

Abstract

OBJECTIVE: An operative technique is described as a salvage treatment for severe subglottic and supraglottic laryngeal stenosis. In addition to expansion of the laryngeal framework with an anterior cartilage graft, as used in a classical laryngotracheal reconstruction, the scar tissue obliterating the airway lumen is excised and a mucosal graft is placed to reconstruct the inner lining of the airway. The graft is harvested from buccal mucosa.
METHODS: The operative technique is outlined. Three cases, 2 paediatric and one adult, with complete or near complete laryngeal stenosis are presented where this operative technique was employed. In all patients several surgeries had been performed previously which were unsuccessful.
RESULTS: In all 3 patients a patent airway was achieved with decannulation of the tracheostomy in the 2 paediatric patients.
CONCLUSIONS: In patients with severe subglottic or supraglottic airway stenosis where other surgeries have failed, excision of endoluminal scar tissue and placement of a buccal mucosal graft, in addition to conventional laryngotracheal reconstruction, is a promising technique. In revision cases of subglottic stenosis cricotracheal resection might not be an option because of scarring from previous surgeries. This operation is an alternative, which allows an increase in the airway lumen by excising the scar tissue then re-lining the exposed internal lumen. The buccal mucosa reduces granulation formation and re-stenosis.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Buccal mucosa; Laryngotracheal reconstruction; Severe laryngeal stenosis; Severe subglottic stenosis; Severe supraglottic stenosis

Mesh:

Year:  2013        PMID: 23993204     DOI: 10.1016/j.ijporl.2013.07.013

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

1.  Biodegradable electrospun patch containing cell adhesion or antimicrobial compounds for trachea repair in vivo.

Authors:  Jakob M Townsend; Makenna E Hukill; Kar-Ming Fung; Devan G Ohst; Jed K Johnson; Robert A Weatherly; Michael S Detamore
Journal:  Biomed Mater       Date:  2020-02-17       Impact factor: 3.715

2.  Surgical Treatment of Iatrogenic Ventral Glottic Stenosis Using a Mucosal Flap Technique.

Authors:  Justine Kane-Smyth; Timothy P Barnett; John Mark O'Leary; Padraic M Dixon
Journal:  Vet Surg       Date:  2016-03-25       Impact factor: 1.495

3.  GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering.

Authors:  Angela Tait; Toby Proctor; Nick J I Hamilton; Martin A Birchall; Mark W Lowdell
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

4.  Bioengineered airway epithelial grafts with mucociliary function based on collagen IV- and laminin-containing extracellular matrix scaffolds.

Authors:  Nick J I Hamilton; Dani Do Hyang Lee; Kate H C Gowers; Colin R Butler; Elizabeth F Maughan; Benjamin Jevans; Jessica C Orr; Conor J McCann; Alan J Burns; Sheila MacNeil; Martin A Birchall; Christopher O'Callaghan; Robert E Hynds; Sam M Janes
Journal:  Eur Respir J       Date:  2020-06-18       Impact factor: 33.795

5.  Using a Three-Dimensional Collagen Matrix to Deliver Respiratory Progenitor Cells to Decellularized Trachea In Vivo.

Authors:  Nick J I Hamilton; Robert E Hynds; Kate H C Gowers; Angela Tait; Colin R Butler; Colin Hopper; Alan J Burns; Martin A Birchall; Mark Lowdell; Sam M Janes
Journal:  Tissue Eng Part C Methods       Date:  2019-02       Impact factor: 3.056

6.  Reinforced Electrospun Polycaprolactone Nanofibers for Tracheal Repair in an In Vivo Ovine Model.

Authors:  Jakob M Townsend; Lindsey M Ott; Jean R Salash; Kar-Ming Fung; Jeremiah T Easley; Howard B Seim; Jed K Johnson; Robert A Weatherly; Michael S Detamore
Journal:  Tissue Eng Part A       Date:  2018-05-10       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.